Highlights from this edition:
- Epic Sciences, In. closed a $24mm Series A Financing, led by Domain Associates, L.L.C., Arsenal Capital Partners, Deerfield Management Company, L.P. Series C, Blue Ox Healthcare Partners, LLC, Labcorp Venture Fund
- Mission Bio, Inc. closed a Series A Financing, led by Fulgent Genetics, Inc. (NasdaqGM:FLGT)
- Sangon Biotech Engineering (Shanghai) Company Limited closed a $290.4mm Series A Financing, led by GL Capital Group, Greenwoods Investment, Huagai Capital Co., Ltd., CDB Technology Venture Capital Co., Ltd., CPE Yuanfeng, Beiguang Huagai Private Equity Fund Management (Beijing) Co., Ltd.